IntroductionStudies have shown that 25% of men diagnosed with cancer are usually diagnosed with prostate cancer. It has progressed so much that it is the third common cause of death in men in the United States. Prostate cancer drugs have made a lot of progress in just the last 10 years. The chances of survival and pain control have improved greatly with the evolution of chemotherapy drugs. Chemotherapy is a treatment that uses the bloodstream to spread throughout the body to repair and kill cancer cells. It is capable of killing cells in organs, lymph nodes, bones, lungs and even cancer cells that have metastasized. It is able to destroy these cells even when they have spread from the prostate region to other areas. This drug is able to kill cancerous and non-cancerous cells that sprout and replicate by circulating the drug in the bloodstream. This drug is prescribed in small doses so that healthy cells are still able to live without being affected by chemotherapy drugs, by adjusting the frequency and dosage of the drug. This therapy is usually used once prostate cancer has started to spread in order to control the spread as much as possible. It is usually able to do this by combining with other drugs to stop the spread of cancer cells in the body. These drugs can have various side effects, from common side effects such as diarrhea to life-threatening effects such as kidney failure. One of the most common cancers found in men is prostate cancer. The prostate is one of the reproductive organs of the male body. The main function of this part of the body is to produce ejaculatory fluid. It is located in the front of the rectum and under the bladder, around the urethra. This specific cancer has been found to affect older men and… middle of paper… omits a longer survival period for these patients as well. With the help of further research and clinical trials of drugs such as docetaxel, cabazitaxel and estramustine it will be possible to treat advanced prostate cancer so that the chances of survival increase, the tumors shrink and more tumor cells can be killed. References Appendix Figure 1.0 - Structure of Docetaxel Figure 2.0 - Structure of CabazitaxelFigure 3.0 - Structure of EstramustineWorks Citedhttp://www.cancer.org/treatment/treatmentsandsideeffects/guidetocancerdrugs/estramustinehttp://www.cancer.gov/cancertopics/druginfo/prostatecancerhttp ://journals2.scholarsportal.info.ezproxy .lib.ryerson.ca/details/13419625/v19i0001/165_wldcwepcwtst.xmlhttp://journals2.scholarsportal.info.ezproxy.lib.ryerson.ca/browse/03445704http://www .urologyhealth.org/urology/index.cfm ?article=105